Veradermics Inc

Research Veradermics Inc (MANE) on Bullrun: market cap USD 5.16B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMANE
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.16B
• Financial periodFY2025
• Net income-USD 70.00M
• Free cash flow-USD 71.63M

Valuation Snapshot

latest market cap is USD 5.16B.

About Veradermics Inc

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts;

Frequently asked questions

What is Veradermics Inc's market cap?

Veradermics Inc's market capitalization is USD 5.16B.

What does Veradermics Inc do?

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children.